{"id":46233,"date":"2025-11-10T22:06:49","date_gmt":"2025-11-10T14:06:49","guid":{"rendered":"https:\/\/flcube.com\/?p=46233"},"modified":"2025-11-10T22:06:50","modified_gmt":"2025-11-10T14:06:50","slug":"hbm-holdings-and-evinova-form-ai%e2%80%91powered-biologic-therapy-collaboration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46233","title":{"rendered":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration"},"content":{"rendered":"\n<p><strong>HBM Holdings Limited<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2142:HKG\">HKG: 2142<\/a>) and <strong>Evinova<\/strong>, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-partnership-objectives\">Partnership Objectives<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Joint AI &amp; Digital Platform<\/strong> \u2013 Combine machine\u2011learning algorithms with advanced digital tools to improve discovery, design, and validation of biologic therapeutics.<\/li>\n\n\n\n<li><strong>Ecosystem Building<\/strong> \u2013 Establish an open, collaborative drug\u2011development network where data, models, and insights can be shared across the life\u2011science sector.<\/li>\n\n\n\n<li><strong>Value\u2011Creation<\/strong> \u2013 Increase speed to clinical candidate identification, reduce development time and cost, and foster innovation across partner pipelines.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-evinova-a-digital-life-science-catalyst\">Evinova \u2013 A Digital Life\u2011Science Catalyst<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Industry Position<\/strong> \u2013 Independent health\u2011tech subsidiary of AstraZeneca, focusing on digital transformation within the life\u2011science value chain.<\/li>\n\n\n\n<li><strong>Global Offering<\/strong> \u2013 Provides AI\u2011enabled digital products and services to life\u2011science and healthcare organizations worldwide.<\/li>\n\n\n\n<li><strong>Alignment with HBM Holdings<\/strong> \u2013 The collaboration will extend Evinova\u2019s capabilities into biologic therapy development, complementing HBM\u2019s expertise in biologic and bioprocess technologies.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-impact\">Strategic Impact<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>For HBM Holdings<\/strong> \u2013 Strengthening its platform for biologic development and enhancing its ability to attract global research partners.<\/li>\n\n\n\n<li><strong>For Evinova<\/strong> \u2013 Deepening its footprint within the AstraZeneca Group and expanding its digital technology portfolio into biologics, a rapidly growing segment of the biotech market.<\/li>\n\n\n\n<li><strong>Industry Significance<\/strong> \u2013 The alliance exemplifies a growing trend of AI\u2011driven drug\u2011development ecosystems that promise to streamline innovation cycles across the pharma landscape.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements regarding the future integration of AI technologies, the development timeline of biologic candidates, and the commercial prospects of the cooperation. Actual results may differ materially due to uncertainties and risks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46234,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,93],"tags":[99,130,4442,129,916],"class_list":["post-46233","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-digital","tag-ai","tag-astrazeneca","tag-evinova","tag-hbm-holdings","tag-hkg-2142"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46233\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration\" \/>\n<meta property=\"og:description\" content=\"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46233\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-10T14:06:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-10T14:06:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration\",\"datePublished\":\"2025-11-10T14:06:49+00:00\",\"dateModified\":\"2025-11-10T14:06:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233\"},\"wordCount\":296,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1003.webp\",\"keywords\":[\"AI\",\"AstraZeneca\",\"Evinova\",\"HBM Holdings\",\"HKG: 2142\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46233#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46233\",\"name\":\"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1003.webp\",\"datePublished\":\"2025-11-10T14:06:49+00:00\",\"dateModified\":\"2025-11-10T14:06:50+00:00\",\"description\":\"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46233\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1003.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1003.webp\",\"width\":1080,\"height\":608,\"caption\":\"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46233#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration - Insight, China&#039;s Pharmaceutical Industry","description":"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46233","og_locale":"en_US","og_type":"article","og_title":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration","og_description":"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.","og_url":"https:\/\/flcube.com\/?p=46233","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-10T14:06:49+00:00","article_modified_time":"2025-11-10T14:06:50+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46233#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46233"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration","datePublished":"2025-11-10T14:06:49+00:00","dateModified":"2025-11-10T14:06:50+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46233"},"wordCount":296,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46233#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","keywords":["AI","AstraZeneca","Evinova","HBM Holdings","HKG: 2142"],"articleSection":["Company","Deals","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46233#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46233","url":"https:\/\/flcube.com\/?p=46233","name":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46233#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46233#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","datePublished":"2025-11-10T14:06:49+00:00","dateModified":"2025-11-10T14:06:50+00:00","description":"HBM Holdings Limited (HKG: 2142) and Evinova, an independent health\u2011tech arm of the AstraZeneca Group, today announced a strategic partnership aimed at harnessing AI and digital technology to accelerate the development of innovative biologic therapies and to create an open, AI\u2011driven drug\u2011development ecosystem.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46233#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46233"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46233#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","width":1080,"height":608,"caption":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46233#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"HBM Holdings and Evinova Form AI\u2011Powered Biologic Therapy Collaboration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1003.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46233"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46233\/revisions"}],"predecessor-version":[{"id":46235,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46233\/revisions\/46235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46234"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}